Skip to content

US · AGPU · SOFTWARE - INFRASTRUCTURE

Axe Compute Inc. (AGPU) intrinsic value and stock valuation

$5.71as of 2026-11-21 · Mkt cap 96.55M

Data updated · price as of 2026-11-21

Strongly undervaluedIC value is more than 50% above the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Axe Compute Inc. DCF and intrinsic value

InvestorsCraft values AGPU with the Chepakovich two-stage DCF model — currently rated strongly undervalued. How the model works · Run your own DCF prefilled from AGPU’s statements →

Axe Compute Inc. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Technology · Software - Infrastructure Pittsburgh, PA 15201 axecompute.com

How the business is doing

Fiscal 2011–2025, USD

Revenue
$130K-36.4% 5y CAGRd
20112025
Net income
-$-233.1M
20112025
Free cash flow
-$-42.49M
20112025
Total equity
$47.7M+78.4% 5y CAGRd
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$130K$1.62M$1.63M$1.51M$1.42M
Operating income-$-28.43M-$-10.94M-$-12.12M-$-26.03M-$-20.43M
Net income-$-233.1M-$-12.2M-$-13.98M-$-25.74M-$-19.66M
EPSd-$-13.37M-$-2.24M-$-3.49M-$-6.98M-$-7.18M
Operating cash flow-$-9.96M-$-11.96M-$-13.19M-$-12.37M-$-12.21M
Capital expenditure-$-32.62M-$-10K-$-20K-$-480K-$-960K
Free cash flow-$-42.49M-$-11.97M-$-13.21M-$-12.85M-$-13.17M
Total assets$52.9M$4.97M$14.4M$25.7M$43.8M
Total debt$1.67M$2.13M$2.73M$180K$880K
Net debt-$-9.12M$1.4M-$-6M-$-21.89M-$-27.32M
Total equity$47.7M-$-200K$8.27M$21.8M$40.3M
Cash and short-term investments$10.8M$730K$8.73M$22.1M$28.2M
Income statement
20252024202320222021
Revenue$130K$1.62M$1.63M$1.51M$1.42M
Cost of revenue$70K$830K$610K$510K$490K
Gross profit$50K$800K$1.02M$1M$930K
Research and development expenses$2.15M$30K$120K$320K$320K
Selling, general and administrative expenses$26.3M$8.89M$9.06M$12.5M$11.7M
Other expenses$0.00$2.83M$3.96M$14.2M$9.34M
Operating expenses$28.5M$11.7M$13.1M$27M$21.4M
Cost and expenses$28.6M$12.6M$13.8M$27.5M$21.9M
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$0.00$0.00$0.00$10.7M$0.00
Depreciation and amortization$690K$700K$240K$1.31M$1.34M
Ebitda-$-232.17M-$-10.16M-$-11.77M-$-13.95M-$-12.13M
Operating income-$-28.43M-$-10.94M-$-12.12M-$-26.03M-$-20.43M
Total other income/expenses, net-$-204.43M$80K$100K$300K$110K
Income before tax-$-232.85M-$-10.86M-$-12.02M-$-25.74M-$-20.32M
Income tax expense$0.00$0.00$0.00$0.00-$-660K
Net income-$-233.1M-$-12.2M-$-13.98M-$-25.74M-$-19.66M
Weighted average shares outstanding$17.4M$5.45M$4.01M$3.69M$2.73M
Weighted average diluted shares outstanding$17.4M$5.45M$4.01M$3.69M$2.74M
Balance sheet
20252024202320222021
Cash and short-term investments$10.8M$730K$8.73M$22.1M$28.2M
Net receivables$7.26M$750K$280K$330K$350K
Inventory$0.00$390K$480K$430K$390K
Total current assets$42.8M$2.23M$10.1M$23.4M$29.5M
Property, plant and equipment, net$1.71M$2.43M$3.96M$2.05M$3.33M
Goodwill and intangible assets$0.00$210K$250K$250K$10.8M
Long-term investments$8.26M$0.00$0.00$0.00$0.00
Total non-current assets$10.1M$2.75M$4.34M$2.37M$14.3M
Total assets$52.9M$4.97M$14.4M$25.7M$43.8M
Accounts payable$1.84M$1.14M$1.33M$940K$1.02M
Short-term debt$760K$570K$600K$90K$640K
Deferred revenue$140K$300K$300K$600K$190K
Total current liabilities$4.27M$3.59M$3.95M$3.88M$3.24M
Long-term debt$900K$1.56M$2.13M$90K$240K
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$900K$1.58M$2.19M$90K$270K
Capital lease obligations$1.56M$2.13M$2.58M$180K$880K
Total liabilities$5.17M$5.18M$6.15M$3.97M$3.51M
Common stock$40K$70K$40K$40K$660K
Retained earnings-$-413.52M-$-180.43M-$-167.76M-$-153.78M-$-128.04M
Accumulated other comprehensive income (loss)$0.00$0.00$0.00$0.00$0.00
Total equity$47.7M-$-200K$8.27M$21.8M$40.3M
Total investments$8.26M$0.00$0.00$0.00$0.00
Total debt$1.67M$2.13M$2.73M$180K$880K
Net debt-$-9.12M$1.4M-$-6M-$-21.89M-$-27.32M
Cash flow statement
20252024202320222021
Net income-$-233.1M-$-10.86M-$-12.02M-$-25.74M-$-19.66M
Depreciation and amortization$690K$700K$720K$1.31M$1.34M
Stock-based compensation$0.00$0.00$0.00$520K$920K
Change in working capital$1.16M-$-910K-$-780K$870K-$-1.19M
Accounts receivable$0.00-$-470K$20K$20K-$-20K
Inventory$0.00$100K-$-70K-$-40K-$-100K
Accounts payable$1.01M-$-190K$400K-$-80K-$-350K
Net cash provided by operating activities-$-9.96M-$-11.96M-$-13.19M-$-12.37M-$-12.21M
Investments in property, plant and equipment-$-32.62M-$-10K-$-50K-$-480K-$-960K
Acquisitions, net$0.00$0.00$0.00$0.00-$-9.59M
Net cash used for investing activities-$-31.99M$20K-$-300K-$-480K-$-10.61M
Common stock issued$56M$4.09M$0.00$6.74M$51.2M
Common stock repurchased$0.00$0.00-$0.00-$-30K-$-10K
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$52M$3.94M$150K$6.72M$50.3M
Net change in cash$10.1M-$-7.99M-$-13.34M-$-6.13M$27.5M
Cash at end of period$10.8M$730K$8.73M$22.1M$28.2M
Operating cash flow-$-9.96M-$-11.96M-$-13.19M-$-12.37M-$-12.21M
Capital expenditure-$-32.62M-$-10K-$-20K-$-480K-$-960K
Free cash flow-$-42.49M-$-11.97M-$-13.21M-$-12.85M-$-13.17M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Axe Compute Inc.

        Headquartered in Pittsburgh, Pennsylvania, Axe Compute Inc., established in 2002 and formerly known as Predictive Oncology Inc. until its December 2025 renaming, is an enterprise that leverages profound scientific insights and artificial intelligence (AI) to advance the discovery and development of cancer treatments. The company's operations are divided into two distinct segments. Its Pittsburgh division offers AI-driven services, utilizing an exclusive biobank containing over 150,000 tumor samples, and engineers specialized 3D cell culture models vital for drug advancement. Meanwhile, the Eagan division produces the FDA-approved STREAMWAY System and related products, which facilitate automated medical fluid waste management and direct patient-to-drain fluid disposal. Additionally, Axe Compute maintains a strategic partnership with Every Cure to identify and prioritize existing pharmaceuticals for repurposing.

        CEO
        Christopher Miglino
        Employees
        14
        Beta
        3.45

        Explore

        Frequently asked questions

        What is the intrinsic value of Axe Compute Inc. (AGPU)?

        Axe Compute Inc. (AGPU) is currently strongly undervalued based on the InvestorsCraft IC model — IC value is more than 50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is AGPU undervalued?

        AGPU trades at a price of $5.71 (Nov 21, 2026): strongly undervalued — IC value is more than 50% above the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.